CN109260221A - The eyedrops and its preparation and application of pure natural components - Google Patents
The eyedrops and its preparation and application of pure natural components Download PDFInfo
- Publication number
- CN109260221A CN109260221A CN201811310047.2A CN201811310047A CN109260221A CN 109260221 A CN109260221 A CN 109260221A CN 201811310047 A CN201811310047 A CN 201811310047A CN 109260221 A CN109260221 A CN 109260221A
- Authority
- CN
- China
- Prior art keywords
- salt lake
- eyedrops
- lake bittern
- sodium chloride
- pure natural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The present invention relates to a kind of eyedrops, the eyedrops and its preparation and application of especially a kind of pure natural components.Eyedrops of the present invention is made of the aqueous solution for the salt lake bittern for being 5-10% containing weight percent, and wherein the weight percent content of the sodium chloride in salt lake bittern is less than 1%.The method for preparing the eyedrops of pure natural components, preparation step are sodium chloride, the purification of salt lake bittern, dilution.Conjunctivitis, keratitis, scheroma are treated using salt lake bittern pure natural eyedrops as main component, and crystal macular degeneration can be prevented.Technical solution of the present invention has the characteristics that therapeutic effect is obvious, has no toxic side effect, raw material sources are extensive, preparation process is simple, treatment cost is cheap, using simple.
Description
Technical field
The present invention relates to a kind of eyedrops, the eyedrops and its preparation and application of especially a kind of pure natural components.
Technical background
With the development of economy, scientific and technological progress, network are popularized, and computer, mobile phone have become in our Working Lifes
Essential a part, and computer, mobile phone are often operated, show an increasing trend year by year the disease incidence of eye disease, many people feel
Eye fatigue, blurred vision or even eyesight be decreased obviously, and some wear " U.S. pupil " class contact lenses and suffer from keratitis,
The patient of the various eye disease such as conjunctivitis is also more and more, the more serious eye disease of even maculopathy class be also in it is high-incidence become
Gesture.
Macula lutea is located on eyeball retina, is the most sharp place of vision, has extremely important effect to the eyesight of people.By
It is not red superficial in maculopathy, it is not easy to it finds, and most of maculopathy treats difficulty.
Salt lake is a kind of very high lake of salinity (based on chloride), refers to that salinity is greater than the lake of 35 grams per liters.Salt
Lake bittern water is the saturation mother liquor in salt lake, according in salt lake the main chemical compositions of brine number classify, have carbonate-type,
Sulfate type, also there is chloride type etc., it is enriched with about 200 kinds of saline minerals to salt lake bittern, is important mineral resources.
Salt lake bittern is mainly used for producing salt chemical product at present, conventional process be salt lake bittern is naturally evaporated through salt pan, sand
The process for refining processes such as filter, oxidation, adsorption bleaching obtain stable, high-quality salt lake bittern, then carry out various minerals again
Extraction, and currently with salt lake bittern in terms for the treatment of disease application it is also seldom.
Summary of the invention
The purpose of the present invention is a variety of natural minerals salts and microelement that are rich in using natural salt lake bittern to be had
The characteristics such as some sterilizations, anti-inflammatory, the eye diseases such as conjunctivitis, keratitis, scheroma can effectively be treated by providing one kind, and can be prevented
The eyedrops and its preparation and application of the pure natural components of crystal macular degeneration.
To achieve the above object the technical scheme is that a kind of eyedrops of pure natural components, it is characterised in that institute
The eyedrops stated is made of the aqueous solution for the salt lake bittern for being 5-10% containing weight percent, wherein chlorination in salt lake bittern
The weight percent content of sodium is 0.5-2%.
Above-mentioned salt lake bittern is the pure low sodium chloride salt lake bittern water obtained through process for refining.
The method for preparing the eyedrops of pure natural components, preparation step are as follows:
1) it removes sodium chloride: natural solar evaporation is carried out to salt lake bittern, sodium chloride crystallization is precipitated, obtains the weight of sodium chloride
The salt lake bittern of low sodium chloride of the degree less than 10-20%;
2) it the purification of salt lake bittern: by the salt lake bittern of above-mentioned sodium chloride by sand filtration, oxidation, adsorption bleaching craft, removes
Suspended matter and organic quality object are removed, pure low sodium chloride salt lake bittern water is obtained;
3) it dilutes: after above-mentioned pure low sodium chloride salt lake bittern water is diluted 10-20 times with medicinal water, after bottling i.e.
For with natural salt lake bittern eyedrops as main component.
Above-mentioned salt lake bittern is carbonate-type, sulfate type, the salt lake bittern of chloride type.
The use of the eyedrops of above-mentioned pure natural components, it is characterised in that treat knot using the eyedrops of above-mentioned natural component
Film inflammation, keratitis, scheroma, and crystal macular degeneration can be prevented.
The application method of the eyedrops of pure natural components, it is characterised in that with the eyedrops of the pure natural components of above-mentioned preparation
It is dripped daily into eyes 3-4 times, 1-2 drip every time, 3-7 days courses for the treatment of.
The technical scheme is that in discovery salt lake bittern to treatment conjunctivitis, keratitis, scheroma, and can prevent
On the basis of crystal macular degeneration has good therapeutic effect, by the formula obtained on a large amount of experiment basis and preparation side
Method.Technical solution of the present invention has the following characteristics that 1, therapeutic effect is obvious, without side-effects.This eyedrops is using pure natural
Sterilization possessed by a variety of natural minerals salts that salt lake bittern is rich in, microelement, anti-inflammatory, the spy for removing lipid deposits
Property, pass through natural evaporation using salt lake bittern of the existing scientific method to saturation, concentration, artificial filter, decoloration, purification, divide
From etc. techniques, obtain pure low sodium saturation salt lake bittern, according to different eye disease types, pure low sodium be saturated salt lake bittern
After 10-20 times of dilution, so that it may obtain the eyedrops with adaptable, energy rapid osmotic the various concentration of human body fluid.Utilize the medicament for the eyes
Water control within 3-7 days to 175 patients with the eye diseases such as conjunctivitis, keratitis, scheroma and macular decline
After treatment, curative effect is fairly obvious, without any side effects;2, raw material sources are extensive, preparation process is simple, treatment cost is cheap.Using
In China, the domestic and external salt lake bittern being widely distributed is as raw material, using salt lake bittern used in current salt chemical engineering
Process for refining, while sodium chloride content therein being reduced, this drops can be effectively prevent to the stimulation of eyes, can effectively be controlled
The eye diseases such as the very high conjunctivitis of current disease incidence, keratitis, scheroma and macular decline are treated, treatment cost is very
It is cheap, alleviate the medical expense of patient;3, using simple.The present invention is administered by the way of drops, is had using simple, straight
Connect act at sufferer, the features such as curative effect is fairly obvious.
Specific embodiment
Embodiment 1:
1) it removes sodium chloride: by the salt lake bittern for being taken from jartai salt lake by naturally evaporating, making the chlorine in brine
Change sodium crystallization to be precipitated, after the weight percent content for detecting the sodium chloride in salt lake bittern is 10% or so, by this low sodium chloride
Salt lake bittern is spare;
2) purification of salt lake bittern;Above-mentioned low sodium chloride salt lake bittern water is existing by sand filtration, oxidation, adsorption bleaching etc.
Salt lake bittern process for refining removes suspended matter and organic quality object in low sodium chloride salt lake bittern water, obtains pure low sodium chloride
Salt lake bittern;
3) it dilutes: according to different eye disease types, being diluted above-mentioned pure low sodium chloride salt lake bittern water with medicinal water
10 times, diluted low sodium chloride salt lake bittern water is obtained, the weight percent of sodium chloride contains in the diluted low sodium chloride salt lake bittern water
Amount is 1% or so, is the eyedrops of pure natural components after bottling.
The eye disease such as chronic conjunctivitis, keratitis, scheroma can be treated using the eyedrops of the pure natural components, are commonly used
The eyedrops can also effectively prevent macular to decline.
In use, 3-4 are dripped into eyes daily with natural salt lake bittern eyedrops as main component with above-mentioned preparation
Secondary, 1-2 drop, 3-5 days courses for the treatment of are suffering from eye disease and the Huangs such as chronic conjunctivitis, keratitis, scheroma to 175 every time
After the persons suffering from ocular disorders of spot visual impairment carries out treatment in 3-7 days, curative effect is fairly obvious, without any side effects.
Embodiment 2-4:
On the basis of embodiment 1, preparation method is same as Example 1, concentration of salt lake bittern extension rate, sodium chloride
With patient numbers and use number of days such as following table.
It is above-mentioned be that the concentration of sodium chloride in example is weight percentage concentration.
In example 2, salt lake bittern is derived from the saturation mother liquor in Qinghai Chaerhan salt lakes, for patient be chronic knot
Film inflammation, keratitis;
In embodiment 3, salt lake bittern is derived from the saturation mother liquor in the salt pond great Chai Dan of Qinghai, for patient be acute knot
Film inflammation, keratitis;
In example 4, salt lake bittern is derived from the saturation mother liquor in the salt lake little Chai Dan of Qinghai, for patient be it is Macular
Visual impairment and xerophthalmia patients.
Application method is daily 3-4 times, every time 1-2 drop, after 3-7 days, chronic conjunctivitis, keratitis, acute knot
Film inflammation, the symptom of keratitis are all eliminated, and macular declines, the symptom of xerophthalmia patients substantially eliminates, no any secondary work
With.
Claims (6)
1. a kind of eyedrops of pure natural components, it is characterised in that the eyedrops is by being 5-10% containing weight percent
Salt lake bittern aqueous solution composition, wherein in salt lake bittern sodium chloride weight percent content be 0.5-2%.
2. according to the eyedrops of pure natural components described in right 1, it is characterised in that above-mentioned salt lake bittern is obtained through process for refining
The pure low sodium chloride saturation salt lake bittern arrived.
3. the method for preparing the eyedrops of pure natural components, preparation step are as follows:
1) it removes sodium chloride: natural solar evaporation is carried out to salt lake bittern, sodium chloride crystallization is precipitated, obtains the weight percent of sodium chloride
The salt lake bittern of low sodium chloride than content less than 10-20%;
2) it the purification of salt lake bittern: by the salt lake bittern of above-mentioned low sodium chloride by sand filtration, oxidation, adsorption bleaching craft, removes
Suspended matter and organic quality object obtain pure low sodium chloride salt lake bittern water;
3) dilute: with medicinal water will after above-mentioned pure low sodium chloride salt lake bittern water dilutes 10-20 times, be after bottling with
Natural salt lake bittern eyedrops as main component.
4. preparing the method for the eyedrops of pure natural components according to right 3, it is characterised in that above-mentioned salt lake bittern is carbon
Hydrochlorate type, sulfate type, the salt lake bittern of chloride type.
5. the use of the eyedrops of above-mentioned pure natural components, it is characterised in that treat conjunctiva using the eyedrops of above-mentioned natural component
Inflammation, keratitis, scheroma, and crystal macular degeneration can be prevented.
6. the application method of the eyedrops of pure natural components, it is characterised in that the eyedrops with the pure natural components of above-mentioned preparation is every
It is dripped 3-4 times into eyes, and 1-2 drip every time, 3-7 days courses for the treatment of.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811310047.2A CN109260221A (en) | 2013-07-17 | 2013-07-17 | The eyedrops and its preparation and application of pure natural components |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013102999792A CN103340901A (en) | 2013-07-17 | 2013-07-17 | Eyedrop with all natural ingredients as well as preparation method and using method of eyedrop |
CN201811310047.2A CN109260221A (en) | 2013-07-17 | 2013-07-17 | The eyedrops and its preparation and application of pure natural components |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013102999792A Division CN103340901A (en) | 2013-07-17 | 2013-07-17 | Eyedrop with all natural ingredients as well as preparation method and using method of eyedrop |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109260221A true CN109260221A (en) | 2019-01-25 |
Family
ID=49275762
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013102999792A Pending CN103340901A (en) | 2013-07-17 | 2013-07-17 | Eyedrop with all natural ingredients as well as preparation method and using method of eyedrop |
CN201811310047.2A Pending CN109260221A (en) | 2013-07-17 | 2013-07-17 | The eyedrops and its preparation and application of pure natural components |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013102999792A Pending CN103340901A (en) | 2013-07-17 | 2013-07-17 | Eyedrop with all natural ingredients as well as preparation method and using method of eyedrop |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN103340901A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001322936A (en) * | 2000-05-15 | 2001-11-20 | Lion Corp | Ophthalmic composition |
CN1947687A (en) * | 2006-03-29 | 2007-04-18 | 成都死海盐疗健康馆服务有限公司 | Salt solution with sterilization function |
CN101164886A (en) * | 2007-09-28 | 2008-04-23 | 山西大学 | Method for purifying and decoloring salt lake brine |
CN103083354A (en) * | 2011-11-01 | 2013-05-08 | 苏州太湖美药业有限公司 | Compound sodium chloride eye drops |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2803205B1 (en) * | 1999-12-31 | 2002-10-18 | Goemar Lab Sa | AQUEOUS IONIC SOLUTIONS AND THEIR USES, ESPECIALLY IN OPHTHALMOLOGY |
JP2008081439A (en) * | 2006-09-27 | 2008-04-10 | Ako Kasei Co Ltd | Ophthalmic solution for preventing and treating conjunctivitis |
-
2013
- 2013-07-17 CN CN2013102999792A patent/CN103340901A/en active Pending
- 2013-07-17 CN CN201811310047.2A patent/CN109260221A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001322936A (en) * | 2000-05-15 | 2001-11-20 | Lion Corp | Ophthalmic composition |
CN1947687A (en) * | 2006-03-29 | 2007-04-18 | 成都死海盐疗健康馆服务有限公司 | Salt solution with sterilization function |
CN101164886A (en) * | 2007-09-28 | 2008-04-23 | 山西大学 | Method for purifying and decoloring salt lake brine |
CN103083354A (en) * | 2011-11-01 | 2013-05-08 | 苏州太湖美药业有限公司 | Compound sodium chloride eye drops |
Non-Patent Citations (2)
Title |
---|
张文挺等: "《临床诊疗技术规范》", 31 August 2007, 内蒙古人民出版社 * |
秦俊法: "论卤盐养生(3)", 《广东微量元素科学》 * |
Also Published As
Publication number | Publication date |
---|---|
CN103340901A (en) | 2013-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104288334A (en) | Traditional Chinese medicine eye drop for relieving eyestrain and preparation method thereof | |
CN102631558B (en) | Medicament for treating eye disease and preparation method of medicament | |
CN107028973B (en) | Eye drops for relieving asthenopia and preparation method thereof | |
CN103860625A (en) | Cranberry extract eye ophthalmic preparation and preparation method and uses thereof | |
CN101890116A (en) | Anthocyanin health-care eye drops and preparation method thereof | |
CN109430856A (en) | A kind of eye-protecting improves the Ricipe for health care food and preparation method thereof of visual fatigue | |
CN110496215A (en) | A kind of aqueous ophthalmic solution and preparation method thereof for treating presbyopia | |
EP3799567B1 (en) | Eye drops comprising citric acid as the sole active ingredient | |
CN109260221A (en) | The eyedrops and its preparation and application of pure natural components | |
CN1259081C (en) | Oral liquid for treating ophthalmic diseases | |
CN103638526B (en) | A kind of blood purification preparation and preparation method thereof and application | |
RU2012120096A (en) | OPHTHALMIC DRUGS BASED ON BDNF (NEUROTROPHIC BRAIN FACTOR) AND THEIR APPLICATION | |
CN103340900A (en) | Natural salt lake brine drop for treating rhinitis as well as preparation method and usage method of natural salt lake brine drop | |
RU2512801C1 (en) | Therapeutic eye balsam | |
CN107375206A (en) | A kind of high biocidal property pearl eyesight improvement drops | |
CN105983006A (en) | Composition for relieving visual fatigue and preparation method of composition | |
CN103316036A (en) | Pure natural artificial tear and its preparation method | |
CN108273037A (en) | A kind of antifatigue eye drops of the albumen containing silverfish | |
CN107137713A (en) | With flushing liquor and preparation method thereof after a kind of ophthalmologic operation | |
CN103356699A (en) | Natural salt lake brine drop for treating tympanitis, and preparation method thereof | |
CN105726767A (en) | Traditional Chinese medicine eye drops for easing eye strain and preparation method of traditional Chinese medicine eye drops | |
CN1265803C (en) | Balsam pear frost eye medicament for preventing and treating eataract, vision fatigue | |
CN1287806C (en) | Preparation and technique for making compound leech eye drip | |
WO2009011613A1 (en) | Composition for washing the nasal cavity, rhinopharynx and the mouth cavity | |
CN1198636C (en) | Application of dandelion herb in preparing medicines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190125 |
|
WD01 | Invention patent application deemed withdrawn after publication |